Efficacy and safety of Lenvatinib-based combination therapies for patients with unresectable hepatocellular carcinoma: a single center retrospective study

BACKGROUND: Reports on Lenvatinib-based therapies show promising treatment outcomes for patients with unresectable hepatocellular carcinoma (uHCC). However, the effect and safety of Lenvatinib-based therapies still need to be further studies. METHODS: This was a retrospective, single-center study on...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jian, Wang, Zhen-Guang, Tao, Qi-Fei, Yang, Yun, Yuan, Sheng-Xian, Gu, Fang-Ming, Liu, Hui, Pan, Ze-Ya, Jiang, Bei-Ge, Lau, Wan Yee, Zhou, Wei-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361059/
https://www.ncbi.nlm.nih.gov/pubmed/37483609
http://dx.doi.org/10.3389/fimmu.2023.1198562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361059/
https://www.ncbi.nlm.nih.gov/pubmed/37483609
http://dx.doi.org/10.3389/fimmu.2023.1198562

Ejemplares similares